We measured the nicotine concentrations in tissues after a bolus i.v. administration of [ 3 H]nicotine to rats to characterize the distribution proˆle of nicotine. The kidney showed the greatest distribution of nicotine compared to other tissues including liver, lung, heart, brain, and intestine. We also performed an HPLC assay for the determination of nicotine and its major metabolite, cotinine, and found that cotinine was negligible in the distribution of almost all tissues, except for the kidney and lung. In the kidney, cotinine was detected at a lower level than nicotine, while cotinine tended to be distributed in the lung compared to nicotine. [ 3 H]Nicotine was accumulated in renal slices in a concentration dependent fashion, suggesting that the nicotine uptake in the renal tubules could be mediated by a speciˆc transport system. Unlabeled nicotine, cotinine, and quinidine showed potent inhibitory eŠects on [ 3 H]nicotine uptake by renal slices. In contrast, tetraethylammonium (TEA), cimetidine, and N 1 -methylnicotinamide (NMN), which were substrates of renal organic cation transporters, had no eŠects on the uptake. Theseˆndings suggested that a speciˆc transporter was involved in nicotine transport at the basolateral membranes of rat renal tubules, which could mediate the high accumulation of nicotine from blood into the kidney.
Introduction
Nicotine is the predominant alkaloid contained in tobacco. There have been many studies on the pharmacokinetics of nicotine in both animals and humans. [1] [2] [3] [4] In smokers, nicotine is absorbed not only through the epithelial cells in the lung but also through buccal and nasal mucosa. Especially the pulmonary absorption is extremely rapid, occurring at a rate similar to those after intravenous administration. 5) Once absorbed, nicotine is eliminated rapidly from blood because of its widespread tissue uptake, in addition to its extensive metabolism mainly in the liver. 6, 7) The hepatic metabolism of nicotine brings about various compounds, including cotinine, the primary metabolite of nicotine via the C-oxidation pathway in most mammals. 8, 9) However, nicotine distributes throughout various tissues, including the brain, liver, skeletal muscles, and kidney, where the nicotine concentration arises several times higher than that in plasma. 10) Interestingly, the accumulation of nicotine in the kidney has been found to be extremely high. Although it was suggested that the extensive nicotine distribution into these tissues has been attributed to its hydrophobic properties (log P ＝0.39), 11) little information is available on the uptake mechanism(s) of nicotine in each tissue and also on the factor that determines the disposition kinetics of nicotine. Especially the mechanism of high accumulation in the kidney is still unknown.
In addition to these elimination pathways, both the parent nicotine and its various metabolites are excreted into urine in a pH dependent manner by tubular secretion. 4, 12, 13) Renal tubules express several transporters mediating urinary excretion of organic cations and anions. 14) We previously reported that nicotine was transported unidirectionally from the basolateral to apical side in the monolayers of LLC-PK 1 cells, corresponding to renal tubular secretion. 15) LLC-PK1 cells have been used for studies of the transepithelial transport and accumulation of cationic molecules and drugs interactions. [16] [17] [18] [19] [20] Nicotine appears to interact with the organic cation transport system in LLC-PK 1 cells 20) and also in the renal tubules. [21] [22] [23] Alternatively, a typical organic cationic drug, cimetidine decreased renal nicotine clearance in men. 24) Although we conˆrmed that nicotine secretion could be mediated by a system distinct from the organic cation transporters, 15) the precise mechanism involved in tubular secretion and reabsorption of nicotine has not been fully elucidated.
In the present study, to characterize the tissue distribution of nicotine into various tissues, we evaluated the apparent tissue distribution (K p) in vivo. In addition, further uptake studies using rat renal cortical slices in vitro were performed to reveal the involvement of the speciˆc transporters in nicotine accumulation in the kidney. 3 H]nicotine were administered as a bolus via the catheterized right femoral vein. Blood samples were collected at 0.5, 1, 1.5, 2, 2.5, and 3 min from the left femoral artery. Three minutes after the injection, several tissue specimens were collected immediately after sacriˆcing the rats. The excised tissues were gently washed, weighed, and homogenized in 3 volumes of 0.9z NaCl. The aliquots (100 mL) of plasma and tissues were solubilized in 0.5 mL of NCS II (Amersham International, Buckinghumshire, UK), and the radioactivity was determined in 5 mL of ACS II (Amersham) by liquid scintillation counting. Apparent tissue distribution coe‹cient (K p) of radioactivity was obtained by dividing the radioactivity in tissues by that in plasma.
HPLC analysis of nicotine and cotinine: HPLC assay of nicotine and cotinine was performed according to the method reported previously. 26) Several tissue specimens and blood samples were collected 3 min after a bolus intravenous administration of nicotine (500 nmol W kg, 81.12 mg W kg). The excised tissues were washed, weighed, and homogenized in 3¿20 volumes of 0.9z NaCl. One milliliter of dichloromethane and 0.5 mL of 3 M NaOH were added to 4 mL of a tissue homogenate or a plasma sample, and mixed for 10 min on a rotating device (40 rpm). After centrifugation at 3,000 rpm for 30 min, a 0.5 mL organic layer was added to the same volume of 0.5 N NaOH, shaken vigorously, and then centrifuged again for 2 min. For each experiment, a 50 mL-volume of the dichloromethane layer ltrated through a Milliporeˆlter (SLLG, 0.2 mm) was injected into an LC-10ATvp high-performance liquid chromatograph (Shimadzu, Kyoto, Japan) equipped with a UV spectrophotometric detector (SPD-10Avp, Shimadzu) under the following conditions: column, NUCLEOSIL 50-5, 4.0 mm inside diameter×125 mm (ChemcoPack); precolumn, NUCLEOSIL 50-5, 4.0 mm inside diameter×10.4 mm (ChemcoPack); mobile phase, dichloromethane-diisoprorylether-methanol25z ammonia solution (62:30:7.9:0.1); ‰ow rate, 2 mL W min; temperature, 409 C; wavelength, 260 nm. The substantial detection limits for nicotine and cotinine were 1.74 ng W mL and 3.64 ng W mL, respectively.
Uptake studies by renal cortical slices: Renal cortical slices from male Wistar rats (200¿220 g) were prepared and stored in ice-cold oxygenated incubation buŠer composed of 120 mM NaCl, 16.2 mM KCl, 1 mM CaCl2, 1.2 mM MgSO4, and 10 mM NaH2PO4 W Na2HPO4, pH 7.5, as described previously. 25) Slice weighing 20¿45 mg was placed in a ‰ask containing 3 mL of the incubation buŠer with 14.4 nM [
3 H]nicotine (3.7 kBq W mL). The uptake of [ 3 H]nicotine was carried out at 259 C under an atmosphere of 100z oxygen. D-[
14 C]Mannitol (14.4 nM, 3.7 kBq W mL) was used to estimate the extracellular trapping and nonspeciˆc uptake of [ 3 H]nicotine. After incubation for a speciˆed period, each slice was rapidly removed from the ‰ask, washed twice with 5 mL of ice-cold incubation buŠer, blotted onˆlter paper, weighed, and solubilized in 0.5 mL of NCS II (Amersham). Then the radioactivity was determined in 5 mL of ACS II (Amersham) by liquid scintillation counting.
Estimation of kinetic parameters: In rat renal cortical slices, the kinetic parameters for nicotine uptake were estimated using the following equation; V 0 ＝ V * max S W (Km+S )+K d *S, where V0 is the uptake rate of the drug ( mmol W g wet tissue W 15 min), S is the nicotine concentration in the medium ( mM), Vmax is the maximum uptake rate by the saturable process ( mmol W g wet tissue W 15 min), and K d is the coe‹cient of simple diŠu-sion (mL W g wet tissue W 15 min). The observed uptake data wereˆtted to the above equation by nonlinear least squares regression analysis.
Statistical analysis: Data were analyzed statistically by one-way analysis of variance followed by ScheŠe's test. Probability values less than 5z were considered signiˆcant.
Results
Tissue distribution of nicotine in rats: To determine the distribution of nicotine in various tissues, we measured the plasma radioactivity 3 min after a bolus i.v. administration of [ 3 H] nicotine (Fig. 1) . After administration of the trace dose (0.72 nmol W kg, 0.12 mg W kg) and high dose (500 nmolW kg, 81.12 mg W kg) of [ 3 H]nicotine, the AUC0-3min calculated by the trapezoidal rule were 0.301±0.026 and 234.16±37.44 ng・min W mL (mean±S.E., n＝4), respectively. Table 1 shows the radioactivity in various tissues and the apparent K p values 3 min after the [ 3 H]nicotine administration in rats. The high radioactivity was found in all tissues, especially in the kidney where the tissue W plasma ratio was the highest among the other tissues. The ratio of the radioactivity in the kidney appeared to be around 25, whereas the values in other tissues were in the range between 3 and 6. The apparent K p values estimated from these tissue and plasma were depicted in Fig. 2 .
Measurement of nicotine and cotinine in tissues after the administration of nicotine: Since it has been reported that nicotine is metabolized to various compounds in physiological conditions, 6) we measured both nicotine and a major metabolite, cotinine, after the administration of unlabeled nicotine (500 nmol W kg, 81.12 mg W kg) by HPLC. Up to 3 min after the administration, cotinine was not detected in most tissues except for the kidney and the lung ( Table 2) . Cotinine tended to be distributed into the lung, where the concentration of cotinine was found around 4 fold higher than nicotine. In the kidney, the detection of cotinine was much weaker than that of nicotine, about one seventh of the nicotine concentration. The K p for cotinine in the kidney was about 30, the same as for nicotine. We also found that these concentrations of nicotine in other tissues were comparable with those analyzed by radioactive tracer (Tables 1 and 2) .
Accumulation of nicotine in rat renal cortical slices: We focused on the uptake mechanism(s) of nicotine in the renal proximal tubules, and performed further uptake studies using rat renal cortical slices. Figure 3 shows the time course of [ 3 H]nicotine uptake using rat renal cortical slices. The uptake of nicotine in renal slices was gradually increased with time under the control conditions. The slice W medium ratio of [ EŠects of various compounds on nicotine uptake in renal cortical slices: Next, to examine the substrate speciˆcity of the transport system(s) in renal cortical slices, the eŠects of several compounds (1 mM) on [ (Fig. 4) . However, tetraethylammonium (TEA), cimetidine, and N 1 -methylnicotinamide (NMN), which appeared to be substrates of renal organic cation transporters, had no eŠects on the uptake. Levo‰oxacin, a ‰uoroquinolone antibacterial drug, had no in‰uence on the uptake. On the other hand, the accumulation of [ 3 H]nicotine was markedly inhibited in the presence of quinidine.
Concentration dependence of nicotine uptake in renal cortical slices: The accumulation of [ 3 H]nicotine in renal cortical slices was measured as a function of substrate concentration. As shown in Fig. 5 
Discussion
To date, many studies were reported concerning the pharmacokinetics of nicotine. 3, 4, 27) In the present study, we evaluated K p for various tissues in vivo to clarify the distribution mechanisms of nicotine, and also performed the uptake studies using rat renal cortical slices in vitro.
Nicotine eliminated immediately from blood, and then the plasma concentration reached the steady state 3 min after the administration (Fig. 1) . In both doses (0.72 nmol W kg and 500 nmol W kg) of [ 3 H]nicotine administrations, the high radioactivity was found in all tissues. The highest K p was observed in the kidney (Fig. 2 and Table 1 ). The signiˆcant high selectivity to kidney suggested that nicotine was distributed to the kidney through transport system(s). Even though the tissue distribution in the kidney was not changed in the case of the high dose of nicotine administration, it could be considered that the nicotine uptake in the kidney was not saturable with the plasma concentration at steady state (43.5 ng W mL) yet. Considering that the K m value of the nicotine uptake by the renal cortical slices was 74.7 mM (12.1 mg W mL) which was signiˆcantly higher than the plasma concentration, and that approximately less than 20z of nicotine was reported to be bound to albumin in rats, the non-saturable tissue distribution even in the high dose administration of nicotine in vivo appeared reasonable.
The plasma concentration of nicotine in smokers depends to a large extent on various factors like the type of tobacco, the depth of inhalation, the pH conditions, age, and so on. Nicotine in the blood of smokers has been found 30¿40 ng W mL right after the inhalation and gradually declined to approximately 20 ng W mL. 28) In the present study, in the rats injected with the high dose (500 nmol W kg) of nicotine, the plasma concentrations at 3 min after the administration reached the same levels as found previously in smokers. Therefore, the K p values after the high dose nicotine injection could be reasonable considering the physiological conditions in smokers.
Even though much eŠort has been made to establish the products of nicotine metabolism, the overall scheme for nicotine metabolism has not been elucidated. At the present time, cotinine is widely recognized as the main primary product of the C-oxidation pathway.
6) It is also useful as a biomarker for tobacco smoke exposure in humans. 27, 29) Since cotinine formation occurs directly from the parent nicotine by rapid oxidation, it has a longer half-life in blood than nicotine that is eliminated at a high rate from the body. In this respect, we clariˆed the contribution of the major metabolite, cotinine, on the radioactivity found in plasma and tissues after a bolus [ 3 H]nicotine administration. As summarized in Table 2 , 3 min after unlabeled nicotine administration (500 nmol W kg), the concentration of cotinine was below the detectable level in all tissues except for the lung and kidney. In the kidney, detection of cotinine was much weaker than that of nicotine, whereas cotinine was accumulated apparently higher in the lung. According to Benowitz et al., 8) nicotine metabolism occurred mainly in the liver, but also to some extent in the lung and kidney. The detection of cotinine in these tissues might have resulted from the participation of these factors. However, considering no detection of cotinine in the liver, it is rather possible that cotinine might have a diŠerent disposition characteristic into the lung. In other words, cotinine metabolized in liver might possibly have a tendency to accumulate in the kidney and lung. Moreover, the unlabeled nicotine concentrations found in tissues by HPLC assay mostly corresponded with those analyzed with the radioactive tracer ( Tables 1  and 2 ). Thus, it was revealed that nicotine was distributed into all tissues, except the lung, as an unchanged form at 3 min after the i.v. administration. Furthermore, theˆndings representing tissue uptake clearance should be considered to directly re‰ect the pharmacokinetics of the parent nicotine itself in smokers.
Uptake studies with rat renal cortical slices indicate the involvement of active transport system(s) for nicotine in the kidney. Since the renal slice technique primarily re‰ects the events associated with the basolateral membranes in renal tubules, 25, 30) the concentrated accumulation shown in Fig. 4 would indicate the potent nicotine transporter(s) expressed in the basolateral membrane in the renal tubules. The kinetics analysis also showed a single component for the uptake (Fig. 5) , which strongly suggested that there was a carriermediated transport system for nicotine. Taking the kinetic parameters analyzed in Fig. 5 into considerations, the contribution of speciˆc transport system would be more than 97z of the total accumulation of nicotine in renal slices at the plasma concentration of nicotine in smokers, being approximately 0.25 mM. Thus, it could be assumed that the speciˆc transport system of nicotine would play a major role for the concentrative nicotine accumulation from plasma into the kidney, rather than a simple diŠusion resulting from the hydrophobic properties of nicotine (Kd＝1.74 mL W g wet tissue W 15 min).
Renal organic cation transporters, rOCT1 and rOCT2, have been well characterized. 14, 31, 32) We demonstrated that nicotine inhibits [
14 C]TEA uptake by rOCT1 and rOCT2, using MDCK cells stably transfected with cDNA encoding for either rOCT1 or rOCT2. 32) The apparent Ki values for nicotine for both rOCT1 and rOCT2 were found around 50 mM, close to the Km value found in renal cortical slices. However, the transport of nicotine was not changed signiˆcantly between either MDCK-rOCT1 or MDCK-rOCT2 and the host cells (data not shown). We also reported that the transport of nicotine was mediated by the system(s) that is distinct from those for organic cations in LLC-PK1 cells. 15) As shown in Fig. 4 , unlabeled nicotine and cotinine showed potent inhibitory eŠects on [ 3 H]nicotine uptake by renal cortical slices, while [ 3 H]nicotine transport was neither inhibited by TEA, cimetidine, nor NMN, which were reported to be substrates of rOCT1 and rOCT2 32) and to inhibit [ A quinolone antibacterial drug, levo‰oxacin, that also decreased nicotine transport in LLC-PK1 cells, again showed no inhibitory eŠect on renal slices. Theseˆnd-ings suggests that nicotine could be mediated by a transport system distinct from rOCT1 or rOCT2 in renal tubules. In addition, the nicotine-speciˆc transport in rat renal cortical slices would have distinct substrate speciˆcities from those in LLC-PK 1 cells.
In conclusion, we clearly demonstrated that nicotine after a bolus i.v. administration was distributed widespread into various tissues, as evaluated by in vivo tissue distribution study. Furthermore, the presentˆnd-ings would suggest that the high accumulation of nicotine in the kidney could be explained by the speciˆc transporter(s) for nicotine in the tubular basolateral membrane that mediates nicotine uptake from the blood into the renal tubular cells.
